ZA9610299B - Pyrazole derivatives process for their preparation and pharmaceutical compositions in which they are present - Google Patents

Pyrazole derivatives process for their preparation and pharmaceutical compositions in which they are present

Info

Publication number: ZA9610299B
Authority: ZA; South Africa
Prior art keywords: preparation; present; pharmaceutical compositions; pyrazole derivatives; derivatives process
Prior art date: 1995-12-08

Application number

ZA9610299A

Other languages

English (en)

Inventor

Francis Barth

Pierre Casellas

Joseph Millan

Didier Oustric

Murielle Rinaldi

Martine Sarran

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-08

Filing date

1996-12-06

Publication date

1997-06-18

1996-12-06 Application filed by Sanofi Sa filed Critical Sanofi Sa

1997-06-18 Publication of ZA9610299B publication Critical patent/ZA9610299B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
150000003217 pyrazoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA9610299A 1995-12-08 1996-12-06 Pyrazole derivatives process for their preparation and pharmaceutical compositions in which they are present ZA9610299B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9514547A FR2742148B1 (fr)	1995-12-08	1995-12-08	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number	Publication Date
ZA9610299B true ZA9610299B (en)	1997-06-18

Family

ID=9485291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9610299A ZA9610299B (en)	1995-12-08	1996-12-06	Pyrazole derivatives process for their preparation and pharmaceutical compositions in which they are present

Country Status (34)

Country	Link
US (1)	US5925768A (de)
EP (2)	EP0868420B1 (de)
JP (1)	JP3510270B2 (de)
KR (1)	KR100488610B1 (de)
CN (1)	CN1101813C (de)
AR (1)	AR004364A1 (de)
AT (1)	ATE191211T1 (de)
AU (1)	AU718763B2 (de)
BR (1)	BR9611986A (de)
CA (1)	CA2239489C (de)
CZ (1)	CZ294307B6 (de)
DE (1)	DE69607484T2 (de)
DK (1)	DK0868420T3 (de)
EE (1)	EE04674B1 (de)
ES (1)	ES2148820T3 (de)
FR (1)	FR2742148B1 (de)
GR (1)	GR3033626T3 (de)
HU (1)	HUP9901244A3 (de)
IL (1)	IL124801A (de)
IS (1)	IS4765A (de)
MX (1)	MX9804565A (de)
MY (1)	MY115228A (de)
NO (1)	NO310683B1 (de)
NZ (1)	NZ323962A (de)
PL (1)	PL186466B1 (de)
PT (1)	PT868420E (de)
RU (1)	RU2170230C2 (de)
SI (1)	SI0868420T1 (de)
SK (1)	SK283706B6 (de)
TR (1)	TR199801041T2 (de)
TW (1)	TW402594B (de)
UA (1)	UA44913C2 (de)
WO (1)	WO1997021682A1 (de)
ZA (1)	ZA9610299B (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5948777A (en) *	1997-03-18	1999-09-07	Smithkline Beecham Corporation	Cannabinoid receptor agonists
CA2340445A1 (en) *	1998-05-04	1999-11-11	The University Of Connecticut	Novel analgesic and immunomodulatory cannabinoids
US7589220B2 (en) *	1998-06-09	2009-09-15	University Of Connecticut	Inhibitors of the anandamide transporter
US7897598B2 (en)	1998-06-09	2011-03-01	Alexandros Makriyannis	Inhibitors of the anandamide transporter
US7161016B1 (en)	1998-11-24	2007-01-09	University Of Connecticut	Cannabimimetic lipid amides as useful medications
US7276613B1 (en)	1998-11-24	2007-10-02	University Of Connecticut	Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US6566560B2 (en)	1999-03-22	2003-05-20	Immugen Pharmaceuticals, Inc.	Resorcinolic compounds
AU3910700A (en)	1999-03-22	2000-10-09	Immugen Pharmaceuticals, Inc.	Treatment of immune diseases
US6900236B1 (en)	1999-10-18	2005-05-31	University Of Connecticut	Cannabimimetic indole derivatives
US7393842B2 (en) *	2001-08-31	2008-07-01	University Of Connecticut	Pyrazole analogs acting on cannabinoid receptors
US6943266B1 (en)	1999-10-18	2005-09-13	University Of Connecticut	Bicyclic cannabinoid agonists for the cannabinoid receptor
CA2387764A1 (en)	1999-10-18	2001-04-26	University Of Connecticut	Peripheral cannabinoid receptor (cb2) selective ligands
CA2387892A1 (en) *	1999-10-18	2001-04-26	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US7741365B2 (en) *	1999-10-18	2010-06-22	University Of Connecticut	Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) *	1999-10-18	2011-12-27	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US7119108B1 (en)	1999-10-18	2006-10-10	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
FR2800372B1 (fr) *	1999-11-03	2001-12-07	Sanofi Synthelabo	Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant
GB0016787D0 (en)	2000-07-07	2000-08-30	Pfizer Ltd	Compounds useful in therapy
US6541510B2 (en) *	2000-09-28	2003-04-01	Immugen Pharmaceuticals, Inc.	Antiviral methods and compounds
WO2002026224A2 (en) *	2000-09-28	2002-04-04	Immugen Pharmaceuticals, Inc.	Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US8449908B2 (en)	2000-12-22	2013-05-28	Alltranz, Llc	Transdermal delivery of cannabidiol
EP1361876A4 (de)	2001-01-26	2004-03-31	Univ Connecticut	Neue cannabimimetische liganden
DE60237431D1 (de)	2001-01-29	2010-10-07	Univ Connecticut	Rezeptor-selektive cannabimimetische aminoalkylindole
US7067539B2 (en) *	2001-02-08	2006-06-27	Schering Corporation	Cannabinoid receptor ligands
US7507767B2 (en) *	2001-02-08	2009-03-24	Schering Corporation	Cannabinoid receptor ligands
JP4312594B2 (ja) *	2001-07-13	2009-08-12	ユニバーシティオブコネチカット	新規な二環式及び三環式カンナビノイド
AU2002319627A1 (en) *	2001-07-20	2003-03-03	Merck And Co., Inc.	Substituted imidazoles as cannabinoid receptor modulators
CA2457922A1 (en) *	2001-08-31	2003-03-13	University Of Connecticut	Novel pyrazole analogs acting on cannabinoid receptors
US7666867B2 (en) *	2001-10-26	2010-02-23	University Of Connecticut	Heteroindanes: a new class of potent cannabimimetic ligands
CN100567266C (zh)	2001-11-14	2009-12-09	先灵公司	类大麻苷受体配体
US20040171613A1 (en) *	2001-12-27	2004-09-02	Japan Tobacco Inc.	Therapeutic agent for non-immediate type allergic diseases
WO2003061699A1 (en) *	2001-12-27	2003-07-31	Japan Tobacco, Inc.	Remedies for allergic diseases
WO2003075917A1 (en)	2002-03-08	2003-09-18	Signal Pharmaceuticals, Inc.	Combination therapy for treating, preventing or managing proliferative disorders and cancers
WO2003080043A1 (en) *	2002-03-18	2003-10-02	Immugen Pharmaceuticals, Inc.	Topical formulations of resorcinols and cannibinoids and methods of use
US6825209B2 (en)	2002-04-15	2004-11-30	Research Triangle Institute	Compounds having unique CB1 receptor binding selectivity and methods for their production and use
DE10226494A1 (de) *	2002-06-14	2004-01-08	Lts Lohmann Therapie-Systeme Ag	Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
DE60319714T2 (de)	2002-06-19	2009-04-02	Schering Corp.	Agonisten des cannabinoidrezeptors
US6972291B2 (en) *	2002-07-02	2005-12-06	Bernstein Richard K	Method for reducing food intake
UY27939A1 (es) *	2002-08-21	2004-03-31	Glaxo Group Ltd	Compuestos
US20060247261A1 (en) *	2002-08-21	2006-11-02	Eatherton Andrew J	Pyrimidine compounds
AU2003265663A1 (en)	2002-08-23	2004-03-11	University Of Connecticut	Keto cannabinoids with therapeutic indications
GB0222493D0 (en) *	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
GB0222495D0 (en) *	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
US7765162B2 (en) *	2002-10-07	2010-07-27	Mastercard International Incorporated	Method and system for conducting off-line and on-line pre-authorized payment transactions
US20040077650A1 (en) *	2002-10-18	2004-04-22	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7129239B2 (en) *	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
WO2004048322A1 (en)	2002-11-25	2004-06-10	Schering Corporation	Cannabinoid receptor ligands
US7247628B2 (en) *	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
CN101012193A (zh) *	2003-01-02	2007-08-08	霍夫曼-拉罗奇有限公司	新cb 1受体反激动剂
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) *	2003-02-10	2007-02-13	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
EP1606019A1 (de) *	2003-03-07	2005-12-21	The University Court of The University of Aberdeen	Inverse agonisten und neutrale antagonisten des cannabinoid-rezeptors als arzneimittel zur behandlung von knochenkrankheiten
TW200505902A (en)	2003-03-20	2005-02-16	Schering Corp	Cannabinoid receptor ligands
US7141669B2 (en) *	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
US20040214856A1 (en) *	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) *	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
MXPA05011922A (es) *	2003-05-07	2006-02-17	Pfizer Prod Inc	Ligandos del receptor de cannabinoides y sus usos.
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US20040259887A1 (en) *	2003-06-18	2004-12-23	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
FR2856683A1 (fr) *	2003-06-25	2004-12-31	Sanofi Synthelabo	Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
FR2862647B1 (fr) *	2003-11-25	2008-07-04	Aventis Pharma Sa	Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
GB0402356D0 (en) *	2004-02-03	2004-03-10	Glaxo Group Ltd	Novel compounds
GB0402357D0 (en) *	2004-02-03	2004-03-10	Glaxo Group Ltd	Novel compounds
GB0402355D0 (en) *	2004-02-03	2004-03-10	Glaxo Group Ltd	Novel compounds
WO2005080350A1 (en) *	2004-02-23	2005-09-01	Glaxo Group Limited	Pyrimidine derivatives as cannabinoid receptor modulators
DE602005009500D1 (de) *	2004-02-24	2008-10-16	Glaxo Group Ltd	Pyridinderivate und deren verwendung als modulatoren des cb2-rezeptors
ITMI20041032A1 (it) *	2004-05-24	2004-08-24	Neuroscienze S C A R L	Compositi farmaceutici
MX2007000015A (es) *	2004-06-22	2007-03-07	Schering Corp	Ligandos de receptor de canabinoide.
EP2343302A1 (de)	2004-07-12	2011-07-13	Cadila Healthcare Limited	Tricyclische pyrazolderivate als cannabinoid- rezeptor modulatoren
US20060025448A1 (en)	2004-07-22	2006-02-02	Cadila Healthcare Limited	Hair growth stimulators
FR2875230A1 (fr) *	2004-09-13	2006-03-17	Sanofi Aventis Sa	Derives de pyrazole condense, leur preparation et leur application en therapeutique
KR20070094747A (ko) *	2004-11-29	2007-09-21	워너-램버트 캄파니 엘엘씨	치료용 피라졸로［３,４-ｂ］피리딘 및 인다졸
JP2008526887A (ja) *	2005-01-10	2008-07-24	ユニバーシティオブコネチカット	カンナビノイド受容体に作用する新規なヘテロピロール類似体
US8853205B2 (en)	2005-01-10	2014-10-07	University Of Connecticut	Heteropyrrole analogs acting on cannabinoid receptors
FR2887550A1 (fr) *	2005-06-24	2006-12-29	Sanofi Aventis Sa	Derives de 1-benzylpyrazole-3-acetamide, leur preparation et leur application en therapeutique
WO2007106721A2 (en) *	2006-03-10	2007-09-20	Jenrin Discovery	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
WO2007121687A1 (en) *	2006-04-26	2007-11-01	Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China	4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
EP2026798A1 (de) *	2006-04-27	2009-02-25	Solvay Pharmaceuticals GmbH	Pharmazeutische zusammensetzungen mit cbx cannabinoid-rezeptor-modulatoren und kaliumkanal-modulatoren
US20070254863A1 (en) *	2006-04-27	2007-11-01	Jochen Antel	Use of CBx cannabinoid receptor modulators as potassium channel modulators
US7763607B2 (en) *	2006-04-27	2010-07-27	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
US7875647B2 (en) *	2006-09-29	2011-01-25	Green Cross Corporation	Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
CA2673177A1 (en)	2006-12-18	2008-06-26	7Tm Pharma A/S	Modulators of cb1 receptors
GB0702862D0 (en) *	2007-02-14	2007-03-28	Univ Aberdeen	Therapeutic compounds
EP1985295A1 (de)	2007-04-04	2008-10-29	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Selektive Inhibitoren der CB2-Rezeptorexpression und/oder Aktivität zur Behandlung von Adipositas und Krankheiten im Zusammenhang mit Adipositas
CN101314591B (zh) *	2007-05-30	2010-09-29	上海阳帆医药科技有限公司	吡唑类高选择性大麻受体-1拮抗剂和/或反向激动剂
FR2916758B1 (fr) *	2007-06-04	2009-10-09	Sanofi Aventis Sa	Derives de 1-benzylpyrazole, leur preparation et leur application en therapeutique
DK2176208T3 (en) *	2007-07-30	2015-04-27	Zynerba Pharmaceuticals Inc	Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
US8367714B2 (en) *	2007-08-28	2013-02-05	Vanderbilt University	Cannabinoid receptor targeted agent
US8133904B2 (en) *	2007-09-07	2012-03-13	Jenrin Discovery, Inc.	Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
CA2698527A1 (en) *	2007-09-20	2009-03-26	Solvay Pharmaceuticals B.V.	5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
US20090247619A1 (en) *	2008-03-06	2009-10-01	University Of Kentucky	Cannabinoid-Containing Compositions and Methods for Their Use
US10053444B2 (en)	2009-02-19	2018-08-21	University Of Connecticut	Cannabinergic nitrate esters and related analogs
EP2311443A1 (de) *	2009-10-15	2011-04-20	Rheinische Friedrich-Wilhelms-Universität	Pharmazeutische Zusammensetzung mit Cannabinoid 2-Rezeptorantagonisten
CN102329192A (zh) *	2011-09-30	2012-01-25	山东天一化学股份有限公司	溴化苄的合成方法
MX387055B (es) *	2014-06-06	2025-03-19	Res Triangle Inst	Agonistas del receptor de apelina (apj) y usos de los mismos.
EP3942934A1 (de)	2015-06-12	2022-01-26	Vettore, LLC	Mct4-inhibitoren zu behandlung von erkrankungen
US10214492B2 (en)	2016-12-12	2019-02-26	Vettore, LLC	Heterocyclic inhibitors of MCT4
US10420089B2 (en)	2017-08-10	2019-09-17	At&T Intellectual Property I, L.P.	Adaptive two-stage downlink control channel structure for code block group based fifth generation (5G) or other next generation systems
CA3125847A1 (en)	2020-07-27	2022-01-27	Makscientific, Llc	Process for making biologically active compounds and intermediates thereof
US12054480B2 (en)	2020-07-31	2024-08-06	Makscientific, Llc	Compounds for treating cannabinoid toxicity and acute cannabinoid overdose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015651A (en) *	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
PH27357A (en) *	1989-09-22	1993-06-21	Fujisawa Pharmaceutical Co	Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2665898B1 (fr) *	1990-08-20	1994-03-11	Sanofi	Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2711140B1 (fr) *	1993-10-12	1996-01-05	Sanofi Sa	1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
FR2714057B1 (fr) *	1993-12-17	1996-03-08	Sanofi Elf	Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.

1995
- 1995-12-08 FR FR9514547A patent/FR2742148B1/fr not_active Expired - Fee Related
1996
- 1996-12-06 HU HU9901244A patent/HUP9901244A3/hu unknown
- 1996-12-06 ZA ZA9610299A patent/ZA9610299B/xx unknown
- 1996-12-06 EE EE9800171A patent/EE04674B1/xx not_active IP Right Cessation
- 1996-12-06 JP JP52178697A patent/JP3510270B2/ja not_active Expired - Fee Related
- 1996-12-06 RU RU98112606/04A patent/RU2170230C2/ru not_active IP Right Cessation
- 1996-12-06 CA CA002239489A patent/CA2239489C/en not_active Expired - Fee Related
- 1996-12-06 IL IL12480196A patent/IL124801A/en not_active IP Right Cessation
- 1996-12-06 DE DE69607484T patent/DE69607484T2/de not_active Expired - Lifetime
- 1996-12-06 EP EP96941716A patent/EP0868420B1/de not_active Expired - Lifetime
- 1996-12-06 TR TR1998/01041T patent/TR199801041T2/xx unknown
- 1996-12-06 PL PL96327177A patent/PL186466B1/pl not_active IP Right Cessation
- 1996-12-06 DK DK96941716T patent/DK0868420T3/da active
- 1996-12-06 UA UA98062944A patent/UA44913C2/uk unknown
- 1996-12-06 SI SI9630209T patent/SI0868420T1/xx unknown
- 1996-12-06 CN CN96199643A patent/CN1101813C/zh not_active Expired - Fee Related
- 1996-12-06 AR ARP960105525A patent/AR004364A1/es active IP Right Grant
- 1996-12-06 NZ NZ323962A patent/NZ323962A/xx not_active IP Right Cessation
- 1996-12-06 PT PT96941716T patent/PT868420E/pt unknown
- 1996-12-06 KR KR10-1998-0704296A patent/KR100488610B1/ko not_active Expired - Fee Related
- 1996-12-06 WO PCT/FR1996/001953 patent/WO1997021682A1/fr not_active Ceased
- 1996-12-06 US US09/077,767 patent/US5925768A/en not_active Expired - Lifetime
- 1996-12-06 AT AT96941716T patent/ATE191211T1/de not_active IP Right Cessation
- 1996-12-06 AU AU11010/97A patent/AU718763B2/en not_active Ceased
- 1996-12-06 SK SK758-98A patent/SK283706B6/sk not_active IP Right Cessation
- 1996-12-06 BR BR9611986A patent/BR9611986A/pt not_active IP Right Cessation
- 1996-12-06 EP EP98401565A patent/EP0885889A3/de not_active Withdrawn
- 1996-12-06 ES ES96941716T patent/ES2148820T3/es not_active Expired - Lifetime
- 1996-12-06 CZ CZ19981775A patent/CZ294307B6/cs not_active IP Right Cessation
- 1996-12-07 MY MYPI96005160A patent/MY115228A/en unknown
- 1996-12-07 TW TW085115150A patent/TW402594B/zh active
1998
- 1998-06-05 NO NO19982589A patent/NO310683B1/no not_active IP Right Cessation
- 1998-06-08 IS IS4765A patent/IS4765A/is unknown
- 1998-06-08 MX MX9804565A patent/MX9804565A/es not_active IP Right Cessation
2000
- 2000-06-07 GR GR20000401312T patent/GR3033626T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0868420B1 (de)	2000-03-29
AR004364A1 (es)	1998-11-04
ATE191211T1 (de)	2000-04-15
PT868420E (pt)	2000-08-31
EP0885889A3 (de)	1999-01-27
JP2000502080A (ja)	2000-02-22
SK283706B6 (sk)	2003-12-02
ES2148820T3 (es)	2000-10-16
PL186466B1 (pl)	2004-01-30
AU718763B2 (en)	2000-04-20
EP0868420A1 (de)	1998-10-07
MX9804565A (es)	1998-09-30
JP3510270B2 (ja)	2004-03-22
SI0868420T1 (en)	2000-10-31
NO310683B1 (no)	2001-08-13
SK75898A3 (en)	1999-01-11
EE04674B1 (et)	2006-08-15
GR3033626T3 (en)	2000-10-31
CA2239489C (en)	2006-05-09
KR19990072004A (ko)	1999-09-27
US5925768A (en)	1999-07-20
TW402594B (en)	2000-08-21
RU2170230C2 (ru)	2001-07-10
PL327177A1 (en)	1998-11-23
NO982589D0 (no)	1998-06-05
CZ177598A3 (cs)	1998-10-14
CA2239489A1 (en)	1997-06-19
FR2742148B1 (fr)	1999-10-22
TR199801041T2 (xx)	1998-08-21
IL124801A0 (en)	1999-01-26
NO982589L (no)	1998-08-03
HUP9901244A2 (hu)	1999-08-30
IL124801A (en)	2004-07-25
EE9800171A (et)	1998-12-15
WO1997021682A1 (fr)	1997-06-19
IS4765A (is)	1998-06-08
CN1101813C (zh)	2003-02-19
CZ294307B6 (cs)	2004-11-10
UA44913C2 (uk)	2002-03-15
DK0868420T3 (da)	2000-08-21
FR2742148A1 (fr)	1997-06-13
KR100488610B1 (ko)	2005-09-26
DE69607484T2 (de)	2000-10-26
HUP9901244A3 (en)	2000-12-28
DE69607484D1 (de)	2000-05-04
NZ323962A (en)	1999-05-28
AU1101097A (en)	1997-07-03
EP0885889A2 (de)	1998-12-23
BR9611986A (pt)	1999-02-17
MY115228A (en)	2003-04-30
CN1207731A (zh)	1999-02-10

Publication	Publication Date	Title
ZA9610299B (en)	1997-06-18	Pyrazole derivatives process for their preparation and pharmaceutical compositions in which they are present
IL117598A (en)	2005-11-20	Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
IL117265A0 (en)	1996-06-18	Benzazepine- benzoxazepine- and benzothiazepine-n-acetic acid derivatives their preparation and pharmaceutical compositions containing them
IL117193A0 (en)	1996-06-18	Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
IL120141A (en)	2000-08-31	Substituted quinazoline derivatives process for their preparation and pharmaceutical compositions containing them
HUP9802300A3 (en)	2002-02-28	N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0000562A3 (en)	2001-12-28	Fused pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
AU4666996A (en)	1996-08-21	Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
ZA945656B (en)	1995-03-09	1-Benzenesfulfonyl-1,3-dihydro-indol-2-one derivatives their preparation and pharmaceutical compositions in which they are present
HUP0001555A3 (en)	2001-01-29	Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
IL119559A0 (en)	1997-02-18	Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
HUP9600071A3 (en)	2000-04-28	Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9602635A2 (en)	1997-11-28	4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9702400A3 (en)	1998-07-28	Substituted camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9600876A3 (en)	2000-04-28	Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
IL117331A0 (en)	1996-07-23	Indole derivatives their preparation and pharmaceutical compositions containing them
ZA9511029B (en)	1997-06-30	Substituted 4-phenylthiazole derivatives process for their preparation and pharmaceutical compositions containing them
HUP0002650A3 (en)	2002-09-30	4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL122377A (en)	2001-01-11	Anti-viral 5-benzoyl-1h-benzimidazoles, process for their preparation and pharmaceutical compositions containing them
HUP9601062A2 (en)	1997-10-28	Chromone derivatives, pharmaceutical compositions containing them and process for their preparation
IL116825A0 (en)	1996-05-14	Vitamin d derivatives their preparation and pharmaceutical compositions containing them
HUP9601751A3 (en)	1999-03-01	Benzothiopyran and thienothiopirane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9801068A3 (en)	2000-02-28	1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
ZA947924B (en)	1995-05-26	Heteroarylpiperidines process for their preparation and pharmaceutical compositions in which they are present
HUP9600173A3 (en)	1998-07-28	4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them